Literature DB >> 21690486

Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice.

Eric J Belin de Chantemèle1, James D Mintz, William E Rainey, David W Stepp.   

Abstract

Although the anorexic effects of leptin are lost in obesity, leptin-mediated sympatho-activation is preserved. The cardiovascular consequences of leptin-mediated sympatho-activation in obesity are poorly understood. We tested the hypothesis that 32 weeks of high-fat diet (HFD) induces metabolic leptin resistance but preserves leptin-mediated sympatho-activation of the cardiovascular system. HFD in mice significantly increased body weight and plasma leptin concentrations but significantly reduced the anorexic effects of leptin. HFD increased heart rate, stroke volume, cardiac output, and plasma aldosterone levels but not blood pressure. As reflected by the contractile response to phenylephrine measured both in vivo and ex vivo, vascular adrenergic reactivity was reduced by HFD, suggesting that reductions in sympathetic tone to the periphery vasculature may mitigate sympatho-activation of the heart and the renin-angiotensin-aldosterone system. Tachyphylaxis was partially restored by symptho-inhibition and not present in ob/ob and db/db mice, despite obesity, arguing for a sympatho-mediated and leptin-specific mechanism. Although infusion of leptin in HFD mice had no effect on heart rate or blood pressure, it further increased aldosterone levels and further reduced vascular adrenergic tone in the absence of weight loss, indicating persistent leptin-mediated stimulation of the cardiovascular system in obesity. In conclusion, these data indicate that, despite metabolic leptin resistance, leptin-mediated stimulation of the heart, the vasculature, and aldosterone production persists in obesity. Blood pressure effects in response to leptin may be limited by a tachyphylactic response in the circulation, suggesting that failure of adrenergic desensitization may be a requisite step for hypertension in the context of obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690486      PMCID: PMC3141100          DOI: 10.1161/HYPERTENSIONAHA.110.168427

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

Review 1.  Uncoupling metabolism and coupling leptin to cardiovascular disease.

Authors:  Allyn L Mark; William I Sivitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

2.  Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses.

Authors:  B M Egan; N J Schork; A B Weder
Journal:  Am J Hypertens       Date:  1989-06       Impact factor: 2.689

Review 3.  The kidney, hypertension, and obesity.

Authors:  John E Hall
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

4.  The relation of adiposity to blood pressure and development of hypertension. The Framingham study.

Authors:  W B Kannel; N Brand; J J Skinner; T R Dawber; P M McNamara
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

5.  Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.

Authors:  Peter Bramlage; David Pittrow; Hans-Ulrich Wittchen; Wilhelm Kirch; Steffen Boehler; Hendrik Lehnert; Michael Hoefler; Thomas Unger; Arya M Sharma
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

Authors:  Rogerio B de Paula; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

8.  Sympathetic activation in obese normotensive subjects.

Authors:  G Grassi; G Seravalle; B M Cattaneo; G B Bolla; A Lanfranchi; M Colombo; C Giannattasio; A Brunani; F Cavagnini; G Mancia
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

9.  Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects.

Authors:  M Maffei; J Halaas; E Ravussin; R E Pratley; G H Lee; Y Zhang; H Fei; S Kim; R Lallone; S Ranganathan
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

10.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

View more
  39 in total

1.  Diet-induced obesity severely impairs myelinated aortic baroreceptor reflex responses.

Authors:  Belinda H McCully; Virginia L Brooks; Michael C Andresen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

2.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

3.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

4.  BK channel β1-subunit deficiency exacerbates vascular fibrosis and remodelling but does not promote hypertension in high-fat fed obesity in mice.

Authors:  Hui Xu; Hannah Garver; Roxanne Fernandes; Jeremiah T Phelps; Jack J Harkema; James J Galligan; Gregory D Fink
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

5.  Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Authors:  Kristen A Baltgalvis; Kathy White; Wei Li; Mark D Claypool; Wayne Lang; Raniel Alcantara; Baljit K Singh; Annabelle M Friera; John McLaughlin; Derek Hansen; Kelly McCaughey; Henry Nguyen; Ira J Smith; Guillermo Godinez; Simon J Shaw; Dane Goff; Rajinder Singh; Vadim Markovtsov; Tian-Qiang Sun; Yonchu Jenkins; Gerald Uy; Yingwu Li; Alison Pan; Tarikere Gururaja; David Lau; Gary Park; Yasumichi Hitoshi; Donald G Payan; Todd M Kinsella
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

Review 6.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 7.  Is obesity a risk factor for chronic kidney disease in children?

Authors:  Sujana S Gunta; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2012-11-14       Impact factor: 3.714

Review 8.  Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction.

Authors:  Ping Gu; Aimin Xu
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

Review 9.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

10.  Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice.

Authors:  Anne-Cécile Huby; Laszlo Otvos; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2016-03-07       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.